Literature DB >> 25943418

Merkel cell carcinoma of the lower leg with retroperitoneal GIST: a very rare association.

Uwe Wollina1, Gesina Hansel, Felicitas Zimmermann, Jacqueline Schönlebe, Andreas Nowak.   

Abstract

Merkel cell carcinoma (MCC) is a rare neuroendocrine tumor of the skin. Although its association with other malignancies is well known, an association with gastrointestinal stromal tumor (GIST) has yet not been described.We report about a 65-year-old female patient who presented with a hypervascularized subcutaneous tumor mass of her left calf. Resection of the primary tumor and histopathological investigations confirmed the diagnosis of MCC. The patient was treated by delayed Mohs surgery, and tumor-free margins were obtained. Sentinel lymph node biopsy was negative for metastatic spread. Primary tumor and lymph node basin were treated by adjuvant radiotherapy. During staging of the patient, a second malignancy-a GIST-was detected. Neoadjuvant treatment with multikinase inhibitor imatinib induced a partial response of GIST that was eventually removed by surgery. However, 8 months later, the patient developed subcutaneous regional metastases of MCC, which were surgically removed. Adjuvant therapy was planned by oncologists.To the best of our knowledge, the occurrence of MCC and GIST in the same patient has yet not been reported. In contrast to GIST, MCC did not respond to imatinib, although c-kit mutations are common in MCC.

Entities:  

Mesh:

Year:  2015        PMID: 25943418     DOI: 10.1007/s00508-014-0660-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  17 in total

1.  Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases.

Authors:  Yoshitsugu Shibayama; Shinichi Imafuku; Akira Takahashi; Juichiro Nakayama
Journal:  Int J Clin Oncol       Date:  2014-04-01       Impact factor: 3.402

2.  Clinical remission of Merkel cell carcinoma after treatment with imatinib.

Authors:  Dagmara Ewa Loader; Robert Feldmann; Magdalena Baumgartner; Friedrich Breier; David Schrama; Jürgen Christian Becker; Andreas Steiner
Journal:  J Am Acad Dermatol       Date:  2013-10       Impact factor: 11.527

Review 3.  Recent advances in the treatment of gastrointestinal stromal tumors.

Authors:  César Serrano; Suzanne George
Journal:  Ther Adv Med Oncol       Date:  2014-05       Impact factor: 8.168

Review 4.  Merkel cell carcinoma: a review and update on aetiopathogenesis, diagnosis and treatment approaches.

Authors:  José Carlos Cardoso; Vera Teixeira; Georgi Tchernev; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2013-08

5.  Merkel cell carcinoma--a retrospective analysis of 17 cases.

Authors:  K Hohaus; E Köstler; J Schönlebe; E Klemm; U Wollina
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-01       Impact factor: 6.166

6.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

Authors:  Charles D Blanke; Cathryn Rankin; George D Demetri; Christopher W Ryan; Margaret von Mehren; Robert S Benjamin; A Kevin Raymond; Vivien H C Bramwell; Laurence H Baker; Robert G Maki; Michael Tanaka; J Randolph Hecht; Michael C Heinrich; Christopher D M Fletcher; John J Crowley; Ernest C Borden
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

7.  Chronic mTOR activation promotes cell survival in Merkel cell carcinoma.

Authors:  Zhenyu Lin; Amelia McDermott; Lijian Shao; Aarthi Kannan; Michael Morgan; Brendan C Stack; Mauricio Moreno; Daniel A Davis; Lynn A Cornelius; Ling Gao
Journal:  Cancer Lett       Date:  2013-11-19       Impact factor: 8.679

8.  Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors.

Authors:  Kelly M Garneski; Ashley H Warcola; Qinghua Feng; Nancy B Kiviat; J Helen Leonard; Paul Nghiem
Journal:  J Invest Dermatol       Date:  2008-07-24       Impact factor: 8.551

Review 9.  Imatinib: a breakthrough of targeted therapy in cancer.

Authors:  Nida Iqbal; Naveed Iqbal
Journal:  Chemother Res Pract       Date:  2014-05-19

Review 10.  Prognostic significance of sentinel lymph node mapping in Merkel cell carcinoma: systematic review and meta-analysis of prognostic studies.

Authors:  Ramin Sadeghi; Zohreh Adinehpoor; Masoud Maleki; Babak Fallahi; Luca Giovanella; Giorgio Treglia
Journal:  Biomed Res Int       Date:  2014-05-26       Impact factor: 3.411

View more
  2 in total

1.  Needle tract seeding and abdominal recurrence following pre-treatment biopsy of gastrointestinal stromal tumors (GIST): results of a systematic review.

Authors:  Jens Jakob; Rashad Salameh; David Wichmann; Nicos Charalambous; Anne-Christine Zygmunt; Inga Kreisel; Judith Heinz; Michael Ghadimi; Ulrich Ronellenfitsch
Journal:  BMC Surg       Date:  2022-05-21       Impact factor: 2.030

2.  Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia.

Authors:  Johanna Waidhauser; Anne Bornemann; Martin Trepel; Bruno Märkl
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.